Subscribe To
Reviva pharmaceuticals: positive results in phase 3 but the stock is back where it started
Results from the phase 3 RECOVER study of Reviva pharmaceuticals' antipsychotic brilaroxazine in schizo...
November 2, 2023, 3:11 am
Corvus pharmaceuticals announces publication of preclinical data demonstrating potential of itk inhibition with soquelitinib as a novel approach to t cell-mediated inflammatory and immune diseases
Data demonstrated soquelitinib was active in six inflammatory/immune disease models and provides rationale for development in a range of additional Th...
November 1, 2023, 11:31 pm
Tarsus to report third quarter 2023 financial results on thursday, november 9, 2023
IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) — Tarsus pharmaceuticals, Inc. (NASDAQ: TARS), whose m...
November 1, 2023, 10:35 pm
Olema oncology to participate in upcoming investor conferences in november
SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) — Olema pharmaceuticals, Inc. (“Olema”, “Olema On...
November 1, 2023, 8:27 pm
Biomarin pharmaceutical, inc. (bmrn) q3 2023 earnings call transcript
Biomarin pharmaceutical, Inc. (NASDAQ:BMRN ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ...
November 1, 2023, 7:36 pm
Ligand pharmaceuticals (lgnd) laps the stock market: here's why
In the most recent trading session, Ligand pharmaceuticals (LGND) closed at $53.30, indicating a +1.93%...
November 1, 2023, 7:32 pm
Ani pharmaceuticals (anip) stock drops despite market gains: important facts to note
ANI pharmaceuticals (ANIP) closed at $61.66 in the latest trading session, marking a -0.13% move from t...
November 1, 2023, 7:32 pm
Tarsus to report third quarter 2023 financial results on thursday, november 9, 2023
IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Tarsus pharmaceuticals, Inc. (NASDAQ: TARS), whose mi...
November 1, 2023, 6:35 pm
Avicanna to hold third quarter 2023 earnings conference call
TORONTO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a bio...
November 1, 2023, 5:55 pm
Hillevax to present at upcoming investor conferences
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical...
November 1, 2023, 4:48 pm
Olema oncology to participate in upcoming investor conferences in november
SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Olema pharmaceuticals, Inc. (“Olema”, “Olema Onc...
November 1, 2023, 4:27 pm
Amphastar pharmaceuticals to release third quarter earnings and hold conference call on november 8, 2023
RANCHO CUCAMONGA, CA / ACCESSWIRE / November 1, 2023 / Amphastar pharmaceuticals, Inc. (NASDAQ:AMPH) an...
November 1, 2023, 4:10 pm
Xenon pharmaceuticals announces conference call and webcast to discuss third quarter 2023 financial results and provide corporate update
VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Xenon pharmaceuticals Inc. (Nasdaq:XENE)...
November 1, 2023, 4:01 pm
Gracell biotechnologies to participate in four upcoming investor conferences
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDA...
November 1, 2023, 4:00 pm
Apellis pharmaceuticals, inc. (apls) q3 2023 earnings call transcript
Apellis pharmaceuticals, Inc. (NASDAQ:APLS ) Q3 2023 Earnings Conference Call November 1, 2023 8:00 AM ...
November 1, 2023, 2:36 pm
Processa pharmaceuticals announces formation of oncology advisory board with renowned key opinion leaders
Company To Leverage World-Class Oncology Advisory Board in the Design of Oncology Trial Protocols, Including the Anticipated Phase 2 Trial for NGC-Cap...
November 1, 2023, 12:15 pm
Mgc pharmaceuticals clarifies share consolidation and new fundraise
MGC pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has provided clarity on the company's consolidati...
November 1, 2023, 11:37 am
Masonic cancer center, university of minnesota to present data in poster presentation human data readout for phase 1 study to evaluate hcw9218 in solid tumors at sitc 38th annual meeting
HCW9218 is the lead product candidate of HCW Biologics Inc. MIRAMAR, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company” or...
November 1, 2023, 11:30 am
Biopharmaceutical stock soars on earnings beat
TG Therapeutics Inc (NASDAQ:TGTX) stock is soaring today, after the biopharmaceutical name's third-quar...
November 1, 2023, 11:29 am
Is medpace (medp) outperforming other medical stocks this year?
Here is how Medpace (MEDP) and Acadia pharmaceuticals (ACAD) have performed compared to their sector so...
November 1, 2023, 11:21 am